CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.
Annborn, Martin LU ; Dankiewicz, Josef LU
; Nielsen, Niklas
LU
; Rundgren, Malin
LU
; Smith, Gustav
LU
; Hertel, S
; Struck, J
and Friberg, Hans
LU
(2014)
In Acta Anaesthesiologica Scandinavica
58(4).
p.428-436
- Abstract
- Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4383470
- author
- Annborn, Martin
LU
; Dankiewicz, Josef
LU
; Nielsen, Niklas
LU
; Rundgren, Malin
LU
; Smith, Gustav
LU
; Hertel, S
; Struck, J
and Friberg, Hans
LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Anaesthesiologica Scandinavica
- volume
- 58
- issue
- 4
- pages
- 428 - 436
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:24617620
- wos:000332609300007
- scopus:84896286972
- pmid:24617620
- ISSN
- 0001-5172
- DOI
- 10.1111/aas.12282
- language
- English
- LU publication?
- yes
- id
- bd489e49-a8c3-4a49-801b-8cb23053a0ba (old id 4383470)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24617620?dopt=Abstract
- date added to LUP
- 2016-04-01 11:15:02
- date last changed
- 2022-01-26 06:35:29
@article{bd489e49-a8c3-4a49-801b-8cb23053a0ba,
abstract = {{Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.}},
author = {{Annborn, Martin and Dankiewicz, Josef and Nielsen, Niklas and Rundgren, Malin and Smith, Gustav and Hertel, S and Struck, J and Friberg, Hans}},
issn = {{0001-5172}},
language = {{eng}},
number = {{4}},
pages = {{428--436}},
publisher = {{Wiley-Blackwell}},
series = {{Acta Anaesthesiologica Scandinavica}},
title = {{CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.}},
url = {{http://dx.doi.org/10.1111/aas.12282}},
doi = {{10.1111/aas.12282}},
volume = {{58}},
year = {{2014}},
}